Profile
Mark Levick served as Global Head-Development at Sandoz Biopharmaceuticals from 2016 to 2019.
Dr. Levick was Chief Executive Officer at Alvotech from 2019 to 2023.
Dr. Levick was Chief Executive Officer & Director at InterAx Biotech AG from 2023 to 2025.
Dr. Levick was Chief Executive Officer at Alvotech hf.
Dr. Levick was Global Head at Novartis AG.
Dr. Levick earned a doctorate from the University of Cambridge and completed undergraduate studies at The University of Newcastle.
Former positions of Mark Levick
| Companies | Position | End |
|---|---|---|
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops a platform for discovery of functionally selective drugs | Chief Executive Officer | 17/10/2025 |
| ALVOTECH | Chief Executive Officer | 01/01/2023 |
Sandoz Biopharmaceuticals | Corporate Officer/Principal | 01/01/2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01/07/2016 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Chief Executive Officer | - |
Training of Mark Levick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Newcastle
The University of Newcastle Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops a platform for discovery of functionally selective drugs | Commercial Services |
Alvotech
Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
Sandoz Biopharmaceuticals |
- Stock Market
- Insiders
- Mark Levick
















